Actively Enrolling Clinical Trials

Research Study
Eligibility Criteria
Contact Person
Emory ADRC Honor Research Registry
Longitudinal study of changes in memory and other cognitive skills
  • Aging people over 65 with no memory problems or
  • People with Mild cognitive impairment or
  • Alzheimer’s disease or other forms of dementia
Katelyn Perkins
404-728-6590
kgperki@emory.edu
Concert (Dimebon) Study
  • Diagnosis of mild to moderate Alzheimer’s disease
  • Age 50 and older
  • Stable on medications
Andrea Kippels
478-951-1453
ajkippe@emory.edu

Vaccine Trials
  • Diagnosis of mild to moderate Alzheimer’s disease
  • Age 50 and older
  • Stable on medications for Alzheimer’s for three months
  • Study partner available to accompany to all visits
Deborah Stout
404-728-6590
dstout@emory.edu

Vaccine Trials
  • Diagnosis of mild to moderate Alzheimer’s disease
  • Age 50 and older
  • Stable on medications for Alzheimer’s for three months
  • Study partner available to accompany to all visits
Deborah Stout
404-728-6590
dstout@emory.edu

Memory Rehabilitation Intervention
in Amnestic Mild Cognitiive Impairment
  • Diagnosed with amnestic mild cognitive impairment
  • Study partner who can attend all cognitive rehabilitation sessions
  • Lives within 45 minutes of Wesley Woods Health Center at Emory University and/or will commit to come to all training sessions
Noah Duncan
404-728-6544
nduncan@emory.edu
Cognitive Rehabilitation in Mild Cognitive Impairment
  • Diagnosed with mild cognitive impairment
  • Willing to undergo functional MRI
Ben Hampstead, PhD
404-712-5667
bhampst@emory.edu
Registry for Remembrance:
An initiative to increase awareness & participation in neurology research
  • Ethnic persons with African Ancestry
  • Aging people over 60 with no memory problems or people of any age with mild memory problems or Alzheimer’s
  • Study partner available to participate in visits
Ezinna Anosike
404-728-6395
eanosik@emory.edu
Lewy Body Disease
  • Diagnosis of probable or possible Lewy Body Disease
  • Stable on medications
  • Willing to spend 72 hours in a sleep research lab
  • Willing to undergo lumbar puncture

Donald Bliwise, Ph.D.
404-728-4750

Neuroimaging Study
  • Diagnosis of Mild Cognitive Impairment or
  • Normal cognition
  • Age 60 years or older
  • Right handed

Katelyn Perkins
404-728-6590
kgperki@emory.edu

August, 2009

Download this information as a PDF.

Research Studies Need Volunteers
When we look back at the advances that have been made over the last 20 years in Alzheimer’s research and review recent research advances, we feel very hopeful that 20 years from now we will be able to prevent the current devastating effects of the disease.  Each step forward, however, requires people willing to participate in research. 

Aging People with No Memory Problems Needed
Normal aging people without memory problems are important to studies designed to learn more about normal memory and aging.  Research studies listed above indicate when aging people without memory problems are needed for studies.

Different Types of Research Studies
Research on Alzheimer’s disease is rapidly advancing on several fronts simultaneously.  Researchers are:

  • Testing potential new medications they hope will be even more effective than currently available treatments. 
  • Using medications approved for other uses (such as cholesterol lowering medications) as potential treatments for Alzheimer’s disease.
  • Looking for ways to identify mild cognitive impairment and Alzheimer’s disease early and monitor the progress of the disease.
  • Learning more about the transition from aging without memory problems to mild cognitive impairment and Alzheimer’s disease
  • Studying how to help individuals and families cope with the disease.

Research Requires Volunteers
Without the past dedication of people with Alzheimer’s disease and their families who participated in clinical trials, we would not have the medicines currently used in treatment.  Many more volunteers are needed for clinical trials that lead to the next generation of medications to treat Alzheimer ’s disease. 

Additional Information
For additional information on the studies listed above please call the Emory Alzheimer’s Disease Research Center at 404-728-6950.